Global Herpes Simplex Virus (HSV) Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 125443
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Herpes Simplex Virus (HSV) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Herpes Simplex Virus (HSV) Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. HSV-1 (Oral Herpes) accounting for % of the Herpes Simplex Virus (HSV) Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While GEN-003 segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Herpes Simplex Virus (HSV) Vaccines include Sanofi, GlaxoSmithKline, Genocea Biosciences, Vical, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Herpes Simplex Virus (HSV) Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

GEN-003

VCL-HB01

HSV529

Others

Market segment by Application can be divided into

HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

The key market players for global Herpes Simplex Virus (HSV) Vaccines market are listed below:

Sanofi

GlaxoSmithKline

Genocea Biosciences

Vical

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Herpes Simplex Virus (HSV) Vaccines product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Herpes Simplex Virus (HSV) Vaccines, with price, sales, revenue and global market share of Herpes Simplex Virus (HSV) Vaccines from 2019 to 2022.

Chapter 3, the Herpes Simplex Virus (HSV) Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Herpes Simplex Virus (HSV) Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Herpes Simplex Virus (HSV) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Herpes Simplex Virus (HSV) Vaccines.

Chapter 13, 14, and 15, to describe Herpes Simplex Virus (HSV) Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Herpes Simplex Virus (HSV) Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 GEN-003

1.2.3 VCL-HB01

1.2.4 HSV529

1.2.5 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 HSV-1 (Oral Herpes)

1.3.3 HSV-2 (Genital Herpes)

1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size & Forecast

1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume (2017-2028)

1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Price (2017-2028)

1.5 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity Analysis

1.5.1 Global Herpes Simplex Virus (HSV) Vaccines Total Production Capacity (2017-2028)

1.5.2 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Herpes Simplex Virus (HSV) Vaccines Market Drivers

1.6.2 Herpes Simplex Virus (HSV) Vaccines Market Restraints

1.6.3 Herpes Simplex Virus (HSV) Vaccines Trends Analysis

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Product and Services

2.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 GlaxoSmithKline

2.2.1 GlaxoSmithKline Details

2.2.2 GlaxoSmithKline Major Business

2.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product and Services

2.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Genocea Biosciences

2.3.1 Genocea Biosciences Details

2.3.2 Genocea Biosciences Major Business

2.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product and Services

2.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Vical

2.4.1 Vical Details

2.4.2 Vical Major Business

2.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Product and Services

2.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Herpes Simplex Virus (HSV) Vaccines Breakdown Data by Manufacturer

3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Herpes Simplex Virus (HSV) Vaccines

3.4 Market Concentration Rate

3.4.1 Top 3 Herpes Simplex Virus (HSV) Vaccines Manufacturer Market Share in 2021

3.4.2 Top 6 Herpes Simplex Virus (HSV) Vaccines Manufacturer Market Share in 2021

3.5 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Herpes Simplex Virus (HSV) Vaccines Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region

4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2017-2028)

4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2028)

4.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028)

4.3 Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028)

4.4 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028)

4.5 South America Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028)

4.6 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Type (2017-2028)

5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)

5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Application (2017-2028)

6.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)

6.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)

7.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)

7.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country

7.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2017-2028)

7.3.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)

8.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)

8.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country

8.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2017-2028)

8.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)

9.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)

9.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Region

9.3.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)

10.2 South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)

10.3 South America Herpes Simplex Virus (HSV) Vaccines Market Size by Country

10.3.1 South America Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2017-2028)

10.3.2 South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)

11.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)

11.3 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country

11.3.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Herpes Simplex Virus (HSV) Vaccines and Key Manufacturers

12.2 Manufacturing Costs Percentage of Herpes Simplex Virus (HSV) Vaccines

12.3 Herpes Simplex Virus (HSV) Vaccines Production Process

12.4 Herpes Simplex Virus (HSV) Vaccines Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Herpes Simplex Virus (HSV) Vaccines Typical Distributors

13.3 Herpes Simplex Virus (HSV) Vaccines Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Sanofi Basic Information, Manufacturing Base and Competitors

Table 4. Sanofi Major Business

Table 5. Sanofi Herpes Simplex Virus (HSV) Vaccines Product and Services

Table 6. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table 8. GlaxoSmithKline Major Business

Table 9. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product and Services

Table 10. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Genocea Biosciences Basic Information, Manufacturing Base and Competitors

Table 12. Genocea Biosciences Major Business

Table 13. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product and Services

Table 14. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Vical Basic Information, Manufacturing Base and Competitors

Table 16. Vical Major Business

Table 17. Vical Herpes Simplex Virus (HSV) Vaccines Product and Services

Table 18. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 21. Market Position of Manufacturers in Herpes Simplex Virus (HSV) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 22. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Company, (K Units): 2020 VS 2021

Table 23. Head Office and Herpes Simplex Virus (HSV) Vaccines Production Site of Key Manufacturer

Table 24. Herpes Simplex Virus (HSV) Vaccines New Entrant and Capacity Expansion Plans

Table 25. Herpes Simplex Virus (HSV) Vaccines Mergers & Acquisitions in the Past Five Years

Table 26. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)

Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2023-2028) & (K Units)

Table 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & (USD Million)

Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028) & (USD Million)

Table 30. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 32. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 34. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2022) & (USD/Unit)

Table 35. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2023-2028) & (USD/Unit)

Table 36. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 37. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 38. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 39. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 40. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2022) & (USD/Unit)

Table 41. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2023-2028) & (USD/Unit)

Table 42. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 43. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)

Table 44. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 45. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 46. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 48. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)

Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 56. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 58. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)

Table 59. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2023-2028) & (K Units)

Table 60. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & (USD Million)

Table 61. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028) & (USD Million)

Table 62. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 64. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 66. South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 67. South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)

Table 68. South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 69. South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 70. South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 71. South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 72. South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 73. South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 74. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)

Table 75. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Region (2023-2028) & (K Units)

Table 76. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & (USD Million)

Table 77. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028) & (USD Million)

Table 78. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 79. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)

Table 80. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 81. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)

Table 82. Herpes Simplex Virus (HSV) Vaccines Raw Material

Table 83. Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines Raw Materials

Table 84. Direct Channel Pros & Cons

Table 85. Indirect Channel Pros & Cons

Table 86. Herpes Simplex Virus (HSV) Vaccines Typical Distributors

Table 87. Herpes Simplex Virus (HSV) Vaccines Typical Customers

List of Figures

Figure 1. Herpes Simplex Virus (HSV) Vaccines Picture

Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type in 2021

Figure 3. GEN-003

Figure 4. VCL-HB01

Figure 5. HSV529

Figure 6. Others

Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application in 2021

Figure 8. HSV-1 (Oral Herpes)

Figure 9. HSV-2 (Genital Herpes)

Figure 10. Global Herpes Simplex Virus (HSV) Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Sales (2017-2028) & (K Units)

Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Price (2017-2028) & (USD/Unit)

Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity (2017-2028) & (K Units)

Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Herpes Simplex Virus (HSV) Vaccines Market Drivers

Figure 17. Herpes Simplex Virus (HSV) Vaccines Market Restraints

Figure 18. Herpes Simplex Virus (HSV) Vaccines Market Trends

Figure 19. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturer in 2021

Figure 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturer in 2021

Figure 21. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Herpes Simplex Virus (HSV) Vaccines Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Herpes Simplex Virus (HSV) Vaccines Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2028)

Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2028)

Figure 26. North America Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (USD Million)

Figure 27. Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (USD Million)

Figure 29. South America Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (USD Million)

Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)

Figure 32. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)

Figure 33. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2028) & (USD/Unit)

Figure 34. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 35. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)

Figure 36. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2028) & (USD/Unit)

Figure 37. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)

Figure 38. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 39. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2028)

Figure 40. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2028)

Figure 41. United States Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)

Figure 45. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 46. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2028)

Figure 47. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2028)

Figure 48. Germany Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2028)

Figure 57. China Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)

Figure 64. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 65. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2028)

Figure 66. South America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines in 2021

Figure 78. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines

Figure 79. Herpes Simplex Virus (HSV) Vaccines Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz